Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2
Marzia Indrigo1, Ilaria Morella2, Daniel Orellana1
1Institute of Experimental Neurology (INSPE), IRCCS San Raffaele Scientific Institute, Milano, Italy.
Abstract:
Cell signaling is central to neuronal activity and its dysregulation may lead to neurodegeneration and cognitive decline. Here, we show that selective genetic potentiation of neuronal ERK signaling prevents cell death in vitro and in vivo in the mouse brain, while attenuation of ERK signaling does the opposite. This neuroprotective effect mediated by an enhanced nuclear ERK activity can also be induced by the novel cell penetrating peptide RB5. In vitro administration of RB5 disrupts the preferential interaction of ERK1 MAP kinase with importinα1/KPNA2 over ERK2, facilitates ERK1/2 nuclear translocation, and enhances global ERK activity. Importantly, RB5 treatment in vivo promotes neuroprotection in mouse models of Huntington's (HD), Alzheimer's (AD), and Parkinson's (PD) disease, and enhances ERK signaling in a human cellular model of HD. Additionally, RB5-mediated potentiation of ERK nuclear signaling facilitates synaptic plasticity, enhances cognition in healthy rodents, and rescues cognitive impairments in AD and HD models. The reported molecular mechanism shared across multiple neurodegenerative disorders reveals a potential new therapeutic target approach based on the modulation of KPNA2-ERK1/2 interactions.
Insights
Enhancing neuronal ERK signaling protects against neurodegeneration and cognitive decline. A novel peptide, RB5, boosts ERK activity, offering a potential therapeutic strategy for diseases like Alzheimer's and Parkinson's.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Cell signaling is crucial for neuronal function.
- Dysregulated signaling contributes to neurodegenerative diseases and cognitive impairment.
Purpose of the Study:
- To investigate the role of ERK signaling in neuroprotection.
- To explore the therapeutic potential of enhancing neuronal ERK activity.
Main Methods:
- Genetic potentiation and attenuation of neuronal ERK signaling.
- In vitro and in vivo studies using cell models and mouse brains.
- Administration of a novel cell-penetrating peptide (RB5).
- Analysis of ERK1/2 nuclear translocation and KPNA2 interactions.
Main Results:
- Enhanced ERK signaling prevents neuronal cell death in vitro and in vivo.
- RB5 peptide facilitates ERK1/2 nuclear translocation and enhances ERK activity.
- RB5 treatment demonstrates neuroprotection in mouse models of Huntington's, Alzheimer's, and Parkinson's diseases.
- RB5 enhances synaptic plasticity and cognitive function in rodents.
Conclusions:
- Modulating KPNA2-ERK1/2 interactions offers a novel therapeutic target for neurodegenerative disorders.
- RB5 peptide represents a promising therapeutic agent for enhancing neuronal resilience and cognitive function.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Nuclear Localization Signals and Import
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


